Stock listing
2B30 Stock Price, News, Filings & Events — Xeris Biopharma Holdings, Inc.
Selected listing: 2B30 · TRADEGATE · EUR · DE
This page tracks Xeris Biopharma Holdings, Inc.'s 2B30:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 2B30:TRADEGATE. 2B30:TRADEGATE is the stock-level entry point for investors researching Xeris Biopharma Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 2B30:TRADEGATE
- Asset type
- Stock
- Market cap
- $1.56B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TRADEGATE
- Currency
- EUR
Xeris Biopharma Holdings, Inc. 2B30:TRADEGATE stock context
This page tracks Xeris Biopharma Holdings, Inc.'s 2B30:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 2B30:TRADEGATE. 2B30:TRADEGATE is the stock-level entry point for investors researching Xeris Biopharma Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Xeris Biopharma Holdings, Inc.
medmix' Drug Delivery ("Haselmeier") to Support the Development of Xeris Pharmaceuticals' XP-8121 with D-Flex(TM) Pen Injector
September 10, 2026
Medmix : rsquo; Drug Delivery (“Haselmeier”) to support the development of Xeris Pharmaceuticals’ XP-8121 with D-Flex™ pen injector
September 10, 2026
Xeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxi...
September 9, 2026
Xeris Announces Details for XP-8121 Program Overview Webinar
August 26, 2026
Xeris Biopharma : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
August 6, 2026
Xeris Biopharma Holdings, Inc. earnings calls
Xeris Biopharma Holdings, Inc. (XERS) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q4 2025 Earnings Call
March 2, 2026 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. investor report
Review AI stock analysis and investor report context for 2B30:TRADEGATE.
Xeris Biopharma Holdings, Inc. company profile
View the public company page for Xeris Biopharma Holdings, Inc. on 6ix.
Xeris Biopharma Holdings, Inc. news
Read company news and market updates connected to Xeris Biopharma Holdings, Inc..
Xeris Biopharma Holdings, Inc. investor events
Find investor webinars, events, and replay context for Xeris Biopharma Holdings, Inc..
Alternate listings
XERS:NASDAQ
US · USD
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
A3C4ZC:LSX
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
A3C4ZC:LS
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
2B3:FWB
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
2B30:GETTEX
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
0A8E:LSE
GB · USD
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
XERS:BOATS
US · USD
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
2B30:DUS
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
2B30:FWB
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
2B30:MUN
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.
2B30:SWB
DE · EUR
Alternate listing for Xeris Biopharma Holdings, Inc.; the primary context on this page is 2B30:TRADEGATE.